This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Aupperle, R L Articles by Gontkovsky, S T Search for Related Content PubMed PubMed Citation Articles by Aupperle, R L Articles by Gontkovsky, S T Social Bookmarking                         What's this?

Three screening batteries to detect cognitive impairment in multiple sclerosis

Departments of Psychiatry and Behavioral Sciences and Neurology, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, Oklahoma 73190, USA

W W Beatty

Departments of Psychiatry and Behavioral Sciences and Neurology, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, Oklahoma 73190, USA, william-beatty{at}ouhsc.edu

F deNAP Shelton

Departments of Psychiatry and Behavioral Sciences and Neurology, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, Oklahoma 73190, USA

S T Gontkovsky

Departments of Psychiatry and Behavioral Sciences and Neurology, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, Oklahoma 73190, USA

To compare the sensitivities for detecting cognitive impairment in patients with multiple sclerosis (MS) and administration times of three brief batteries of neuropsychological tests, 64 patients with MS completed the Neuropsychological Screening Battery for Multiple Sclerosis (NPSBMS), the Screening Examination for Cognitive Impairment (SEFCI), and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Failure on a particular test was defined as a score below the 5th percentile for healthy controls, and the number of patients who failed at least one or two tests (out of four) was determined for each battery. Both the SEFCI and the NPSBMS identified significantly more patients with impairment than the RBANS, which was no more sensitive than the Mini-Mental State Exam (MMSE). Results were similar at both the one- and two-failed-tests criteria, but there were no significant differences between the SEFCI and the NPSBMS at either failure criterion. Mean administration time was 22.6 min for the SEFCI compared to 31.7 min for the NPSBMS (p <0.001). Eleven (17%) of the patients refused to attempt the Paced Auditory Serial Addition Test (PASAT), one component of the NPSBMS. For screening patients on a single occasion, the SEFCI is preferred because its administration time is shorter than the NPSBMS.

Key Words: cognition • demyelinating disease • information processing • memory • multiple sclerosis • screening batteries

Multiple Sclerosis, Vol. 8, No. 5, 382-389 (2002)
DOI: 10.1191/1352458502ms832oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E Portaccio, B Goretti, S Lori, V Zipoli, S Centorrino, A Ghezzi, F Patti, V Bianchi, G Comi, M Trojano, et al. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis Multiple Sclerosis, May 1, 2009; 15(5): 620 - 626. [Abstract] [PDF]

				N Figved, R Benedict, G Klevan, K. Myhr, H. Nyland, N. Landro, J. Larsen, and D Aarsland Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1084 - 1090. [Abstract] [PDF]

				M. Younes, J. Hill, J. Quinless, M. Kilduff, B. Peng, S. Cook, and D. Cadavid Internet-based cognitive testing in multiple sclerosis Multiple Sclerosis, September 1, 2007; 13(8): 1011 - 1019. [Abstract] [PDF]

				A. Solari, A. Motta, D. Radice, and L. Mendozzi A shortened version of PASAT-3 is feasible Multiple Sclerosis, September 1, 2007; 13(8): 1020 - 1025. [Abstract] [PDF]

				P. Scherer, I.K. Penner, A. Rohr, H. Boldt, I. Ringel, H. Wilke-Burger, E. Burger-Deinerth, K. Isakowitsch, M. Zimmermann, S. Zahrnt, et al. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study Multiple Sclerosis, April 1, 2007; 13(3): 402 - 411. [Abstract] [PDF]

				I M Claesson, C Ytterberg, S Johansson, O Almkvist, and L von Koch Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test Multiple Sclerosis, March 1, 2007; 13(2): 272 - 274. [Abstract] [PDF]

				M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet How to detect cognitive dysfunction at early stages of multiple sclerosis? Multiple Sclerosis, August 1, 2006; 12(4): 445 - 452. [Abstract] [PDF]

				J Sepulcre, S Vanotti, R Hernandez, G Sandoval, F Caceres, O Garcea, and P Villoslada Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test Multiple Sclerosis, April 1, 2006; 12(2): 187 - 195. [Abstract] [PDF]